Glitazones are associated with reduced risk of Parkinson’s disease

Click for article

Click for article

Patients who take the antidiabetes drugs rosiglitazone or pioglitazone have a lower risk of developing Parkinson’s disease than patients taking other drugs for diabetes, a study published in PLoS Medicine indicates.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s